
Glenn N Levine MD, FAHA, FACC
Professor of Medicine, Baylor College of Medicine. Director, Cardiac Care Unit, Michael E. DeBakey VA Medical Center; Chair, ACC/AHA Task Force on Clinical Practice GuidelinesRecent Contributions to PracticeUpdate:
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention
- Use of Antiplatelet Therapy/DAPT for Post-PCI Patients Undergoing Noncardiac Surgery
- Risk Associated With Surgery Within 12 Months After Coronary DES Implantation
- Early Cessation of Adenosine Receptor Inhibitors Increases Risk for MACE